在CRSwNP中对杜皮卢马布诱导的血液氨酸的临床管理:一个实用的算法
E De Corso1, M Caminati2, P W Hellings3
1Otolaryngology, Head and Neck Surgery, Rhinology, A. Gemelli Universitary Hospital Foundation, IRCSS, Rome, Italy.
Rhinology
|October 27, 2025
概括
杜比卢马布治疗严重的长期鼻炎与鼻 (CRSwNP) 可能会导致血液中乙基细胞数 (BEC) 的暂时增加,称为杜比卢马布诱导的血液乙基细胞 (DIBE). 这种情况通常是良性的,不会影响治疗的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 杜皮卢马布是严重的慢性鼻炎与鼻 (CRSwNP) 的关键治疗方法.
- 在dupilumab治疗期间,血中乙氨基酸细胞计数 (BEC) 可能会升高.
- 杜比卢马布诱导的血中异敏症 (DIBE) 是已知的现象,跨越了杜比卢马布的适应症.
研究的目的:
- 在CRSwNP.患者中鉴定dupilumab诱导的血红 (DIBE) 的特征.
- 评估DIBE的临床意义和安全概况.
- 为了确定DIBE的发病,持续时间和对dupilumab疗效的影响.
主要方法:
- 审查临床试验数据和现实世界的证据.
- 在用dupilumab治疗的患者中分析血液中乙氨基酸细胞数量 (BEC).
- 与DIBE相关的不良事件 (AE) 的评估.
主要成果:
- 在CRSwNP中,DIBE通常是早期发作的,短暂的,无症状的.
- 埃索诺菲利亚的临床表现很少见,发生在<0.2%的患者中.
- 大多数DIBE病例是良性的;罕见的AE如乙性肺炎可能发生,特别是在EGPA患者中.
- 观察到晚期发病的DIBE (6个月后),特别是在依赖皮质类固醇的患者中.
结论:
- 杜皮卢马布诱导的血中乙 (DIBE) 是一种常见的,通常是CRSwNP患者的良性发现.
- DIBE通常不会影响dupilumab的疗效.
- 对罕见但严重的副作用的监测很重要,特别是在特定患者群体中.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
719
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
719
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:30Epistaxis
510
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
510